Literature DB >> 16359466

Neurocutaneous syndromes and epilepsy-issues in diagnosis and management.

J Helen Cross1.   

Abstract

Epilepsy may be seen as a feature of many of the neurocutaneous syndromes. The challenge lies within the diagnosis of the specific disorder and ultimately control of the epilepsy. Tuberous sclerosis is the most common of the disorders with a frequency of 4.9/100,000. An autosomal-dominant condition, diagnostic features may be unclear under 2 years of age. Population studies suggest a prevalence of epilepsy of 78%, the majority presenting under the age of 12 months, with a high association between the occurrence of seizures and the presence of learning disability. Although an apparent multifocal disease, surgery may have a role to play where seizures are demonstrated to probably arise from a single tuber. Other less common neurocutaneous syndromes also have a high prevalence of epilepsy in association with cerebral malformations; unilateral or lobar malformations should be referred early for surgical consideration. Neurofibromatosis is the second most common of the disorders but the prevalence of epilepsy in this population is relatively low; in addition, a greater proportion may be easier to treat with medication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359466     DOI: 10.1111/j.1528-1167.2005.00353.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

Review 1.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 2.  Potential for treatment of severe autism in tuberous sclerosis complex.

Authors:  Tanjala T Gipson; Gwendolyn Gerner; Mary Ann Wilson; Mary E Blue; Michael V Johnston
Journal:  World J Clin Pediatr       Date:  2013-08-08

Review 3.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

4.  Infantile spasms in the setting of Sturge-Weber syndrome.

Authors:  Massimo Barbagallo; Martino Ruggieri; Gemma Incorpora; Piero Pavone; Caterina Nucifora; Alberto Spalice; Andrea Domenico Praticò; Agata Polizzi; Lorenzo Pavone; Paola Iannetti
Journal:  Childs Nerv Syst       Date:  2008-10-02       Impact factor: 1.475

5.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

Review 6.  Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.

Authors:  Aristea S Galanopoulou; Jan A Gorter; Carlos Cepeda
Journal:  Epilepsia       Date:  2012-05-11       Impact factor: 5.864

Review 7.  New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).

Authors:  Tanjala T Gipson; Michael V Johnston
Journal:  F1000Res       Date:  2017-06-09

8.  A Potential Role for Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the Literature.

Authors:  Natanya M Mishal; Dimitrios Arkilo; Ju Tang; John R Crawford; Sonya G Wang
Journal:  Case Rep Neurol Med       Date:  2015-10-22

9.  Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: A novel epilepsy model.

Authors:  Fei Yang; Lingli Yang; Mari Wataya-Kaneda; Lanting Teng; Ichiro Katayama
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.